Fatal and nonfatal cardiovascular disease and the use of therapies for secondary prevention in a rural region of India

Circulation. 2009 Apr 14;119(14):1950-5. doi: 10.1161/CIRCULATIONAHA.108.819201. Epub 2009 Mar 30.

Abstract

Background: The rate of cardiovascular disease is widely considered to be increasing throughout India. Precise and reliable data on fatal and nonfatal cardiovascular disease, however, are few, and little is known about the use of preventive therapies. This is particularly true for rural regions.

Methods and results: Data were collected from 53 villages in the Godavari region of Andhra Pradesh. Mortality data were obtained from a verbal autopsy-based mortality surveillance system during a 12-month period in 2003 to 2004. The prevalence of nonfatal cardiovascular disease and the use of preventive therapies were estimated from a stratified random sample of 4535 adults (> or =30 years of age) in 2005. Cardiovascular disease was the leading cause of mortality, accounting for at least 32% of all deaths. The average age at cardiovascular death was 65 years, and 51% of all cardiovascular deaths occurred in patients <70 years of age. Among adults, the prevalence of coronary heart disease was estimated to be 4.8% (95% CI, 4.1 to 5.5), and the prevalence of cerebrovascular disease was estimated at 2.0% (95% CI, 1.5 to 2.4). Among individuals with either diagnosis, 14% (95% CI, 10 to 18) reported taking aspirin, 41% (95% CI, 36 to 47) took a blood pressure-lowering medication, and 5% (95% CI, 3 to 7) reported using a cholesterol-lowering medication.

Conclusions: This region has a large disease burden attributable to cardiovascular disease with significant underuse of proven, low-cost preventive medications.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anticholesteremic Agents / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Autopsy
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / mortality*
  • Cardiovascular Diseases / prevention & control
  • Cardiovascular Diseases / therapy*
  • Cost of Illness
  • Humans
  • Incidence
  • India / epidemiology
  • Middle Aged
  • Prevalence
  • Risk Factors
  • Rural Population / statistics & numerical data
  • Secondary Prevention / methods*

Substances

  • Anticholesteremic Agents
  • Antihypertensive Agents